CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia-Reference-Cited by-同舟云学术

CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia

Published:2013-02-07 Issue:6 Volume:121 Page:975-983
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

McNerney Megan E.¹²,Brown Christopher D.¹³,Wang Xiaoyue¹³,Bartom Elizabeth T.⁴,Karmakar Subhradip¹,Bandlamudi Chaitanya¹⁵,Yu Shan¹⁵,Ko Jinkyung⁶,Sandall Barry P.⁶,Stricker Thomas⁷,Anastasi John²,Grossman Robert L.¹⁴,Cunningham John M.⁶,Le Beau Michelle M.¹⁸,White Kevin P.¹³⁹

Affiliation:

1. Institute for Genomics and Systems Biology,

2. Department of Pathology,

3. Department of Human Genetics,

4. Center for Research Informatics,

5. Committee on Genetics, Genomics, and Systems Biology, and

6. Department of Pediatrics, Section of Hematology/Oncology and Stem Cell Transplantation, University of Chicago, Chicago, IL;

7. Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, TN; and

8. Sections of Hematology/Oncology and

9. Genetic Medicine, University of Chicago, Chicago, IL

Abstract

Key PointsCUX1 is a transcription factor encoded on a region of chromosome 7 that is frequently deleted in high-risk acute myeloid leukemia. Haploinsufficiency of CUX1/cut promotes hematopoietic overgrowth in both Drosophila melanogaster and human xenograft mouse models in vivo.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/121/6/975/1368254/zh800613000975.pdf

Reference50 articles.

1. Deletions of chromosome 7 in haematological disorders [letter].;Rowley;Lancet,1973

2. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).;Byrd;Blood,2002

3. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.;Smith;Blood,2003

4. Unraveling the molecular pathophysiology of myelodysplastic syndromes.;Bejar;J Clin Oncol,2011

5. Cytogenetic findings in adult secondary acute myeloid leukemia (AML): frequency of favorable and adverse chromosomal aberrations do not differ from adult de novo AML.;Preiss;Cancer Genet Cytogenet,2010

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploinsufficient Transcription Factors in Myeloid Neoplasms;Annual Review of Pathology: Mechanisms of Disease;2024-01-24

2. Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets;Leukemia;2023-08-26

3. Next-Generation Sequencing–Based Genomic Profiling of Children with Acute Myeloid Leukemia;The Journal of Molecular Diagnostics;2023-08

4. Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets;LEUKEMIA;2023

5. Characterisation of the genetic determinants of context specific DNA methylation in primary monocytes;2023-05-19